6R-methylenetetrahydrofolate: Phase I/II started

Isofol began an open-label, European Phase I/II trial to evaluate 7.5, 15 and 30 mg/m 2 Modufolin in about 6 patients with osteosarcoma receiving treatment with methotrexate. Isofol has exclusive, wor...